Leukemia & Lymphoma, Volume 56, Issue 1 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 1 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary on selected article in this issue

Article Commentary
New anti-CD20 monoclonal antibodies: which is the best?
Anne-Laure Gagez & Guillaume Cartron
Pages: 1-2
Published online: 25 Jun 2014
CitationforNew anti-CD20 monoclonal antibodies: which is the best? | Full Text | References | PDF (95.5 KB) | Supplemental
  • 942 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
A “PET” topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end
Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis & Aaron Polliack
Pages: 3-5
Published online: 04 Aug 2014
First Page PreviewforA “PET” topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end | Full Text | References | PDF (98.3 KB) | Supplemental
  • 1128 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Is there a role for omacetaxine in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors?
Moussab Damlaj & Sarit Assouline
Pages: 6-7
Published online: 25 Jun 2014
CitationforIs there a role for omacetaxine in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors? | Full Text | References | PDF (87.6 KB) | Supplemental
  • 530 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Commentaries on selected articles in this issue

Article Commentary
ABT-199 partners with azacitidine to contest myeloid malignancies
Andrew Wei
Pages: 8-9
Published online: 15 Jul 2014
CitationforABT-199 partners with azacitidine to contest myeloid malignancies | Full Text | References | PDF (88.4 KB) | Supplemental
  • 1149 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Commentary on selected article in this issue

Article Commentary
Splenectomy and second malignancies in patients with Hodgkin lymphoma: is there a causal relationship?
Kailash Mosalpuria & Fausto Loberiza Jr
Pages: 10-11
Published online: 25 Jun 2014
CitationforSplenectomy and second malignancies in patients with Hodgkin lymphoma: is there a causal relationship? | Full Text | References | PDF (88.6 KB) | Supplemental
  • 797 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma
Pier Luigi Zinzani, Massimo Federico, Stefano Oliva, Antonello Pinto, Luigi Rigacci, Giorgina Specchia, Alessandra Tucci & Umberto Vitolo
Pages: 12-25
Published online: 24 Mar 2014
AbstractforThe more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma | Full Text | References | PDF (187.8 KB) | Supplemental
  • 603 Views
  • 9 CrossRef citations
  • 0Altmetric
Review Article
The role of P-glycoprotein in drug resistance in multiple myeloma
Joseph Abraham, Noha N. Salama & Abdel Kareem Azab
Pages: 26-33
Published online: 05 Jun 2014
AbstractforThe role of P-glycoprotein in drug resistance in multiple myeloma | Full Text | References | PDF (265.6 KB) | Supplemental
  • 928 Views
  • 69 CrossRef citations
  • 0Altmetric
Review Article
Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?
Adewale Fawole, Rafat Abonour, Michael Stender, Seerin Shatavi, Susanna Gaikazian, Joseph Anderson & Ishmael Jaiyesimi
Pages: 34-41
Published online: 25 Mar 2014
AbstractforIs it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma? | Full Text | References | PDF (181.6 KB) | Supplemental
  • 559 Views
  • 2 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma
Kristen N. Ganjoo, Sven de Vos, Brad L. Pohlman, Ian W. Flinn, Andres Forero-Torres, Nathan H. Enas, Damien M. Cronier, Nam H. Dang, Kenneth A. Foon, Susan P. Carpenter, Christopher A. Slapak, Brian K. Link, Mitchell R. Smith, Markus Y. Mapara & James E. Wooldridge
Pages: 42-48
Published online: 14 Jul 2014
AbstractforPhase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma | Full Text | References | PDF (1.1 MB) | Supplemental
  • 419 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
The utility and limitations of 18F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review
Chan Y. Cheah, Michael S. Hofman, John F. Seymour, David S. Ritchie, Michael Dickinson, Andrew Wirth, H. Miles Prince, Max Wolf, Elchanan H. Januszcewicz, Dennis A. Carney, Kirsten E. Herbert, Simon J. Harrison, Kate L. Burbury & Constantine S. Tam
Pages: 49-56
Published online: 16 Jun 2014
AbstractforThe utility and limitations of 18F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review | Full Text | References | PDF (481.7 KB) | Supplemental
  • 353 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial
Robert Pytlík, David Belada, Kateřina Kubáčková, Ingrid Vášová, Tomáš Kozák, Jan Pirnos, Ingrid Bolomská, Milan Matuška, Jana Přibylová, Vít Campr, Lucie Burešová, Alice Sýkorová, Adéla Berková, Pavel Klener, Marek Trněný & for the Czech Lymphoma Study Group
Pages: 57-64
Published online: 29 Apr 2014
AbstractforTreatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial | Full Text | References | PDF (538.6 KB) | Supplemental
  • 409 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile
Yu-Yu Tien, Brian K. Link, John M. Brooks, Kara Wright & Elizabeth Chrischilles
Pages: 65-71
Published online: 22 Apr 2014
AbstractforTreatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile | Full Text | References | PDF (995.8 KB) | Supplemental
  • 516 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis
Chun Chao, Roberto Rodriguez, John H. Page, Su-Jau Yang, Julie Huynh & Victoria M. Chia
Pages: 72-79
Published online: 02 May 2014
AbstractforHistory of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis | Full Text | References | PDF (654.2 KB) | Supplemental
  • 332 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
A single institution experience of extranodal natural killer/T cell lymphoma of nasal type
Luluel Khan, David Hodgson, Alex Sun, Mary Gospodarowicz, Michael Crump, John Kuruvilla, Melania Pintilie & Richard Tsang
Pages: 80-84
Published online: 31 Mar 2014
AbstractforA single institution experience of extranodal natural killer/T cell lymphoma of nasal type | Full Text | References | PDF (861.9 KB) | Supplemental
  • 219 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia
Xiao Liu, Dao Feng Wang, Yi Fang, Wen Feng Ye, Shu Liu & Ning Lou
Pages: 85-91
Published online: 17 Jun 2014
AbstractforInitial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia | Full Text | References | PDF (223.5 KB) | Supplemental
  • 361 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity
Colin Phipps, Ajay K. Gopal, Barry E. Storer, Ryan D. Cassaday, Oliver W. Press, Brian G. Till, John M. Pagel, Maria C. Palanca-Wessels, Mary Philip, William I. Bensinger, Leona A. Holmberg, Andrei R. Shustov, Damian J. Green, Thomas Chauncey, David G. Maloney & Edward N. Libby III
Pages: 92-96
Published online: 17 Jun 2014
AbstractforAutologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity | Full Text | References | PDF (381.2 KB) | Supplemental
  • 278 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia
Isabelle Herth, Manfred Hensel, Michael Rieger, Kristin Horstmann, Wolfgang Hiddemann, Martin Dreyling, Silvia Koniczek, Mathias Witzens-Harig & Anthony D. Ho
Pages: 97-102
Published online: 25 Jun 2014
AbstractforPentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia | Full Text | References | PDF (253.7 KB) | Supplemental
  • 242 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells
Margarida Lima, Ana Spínola, Sónia Fonseca, Ana Helena Santos, João Rodrigues, Lurdes Oliveira, Maria Luís Queirós, Marlene Santos, Marta Gonçalves, Catarina Lau, Maria dos Anjos Teixeira, Cristina Gonçalves, Cristina Marques, Manuel Guerreiro, Manuel Cunha, Fernando Príncipe & Jorge Coutinho
Pages: 103-112
Published online: 06 May 2014
AbstractforAggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells | Full Text | References | PDF (1.7 MB) | Supplemental
  • 417 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia
Nashwa Khairat Abousamra, Manal Salah El-Din, Eman Hamza Elzahaf & Mohammed Ebrahim Esmael
Pages: 113-119
Published online: 05 Jun 2014
AbstractforEctonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia | Full Text | References | PDF (1.3 MB) | Supplemental
  • 232 Views
  • 19 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors
H. Jean Khoury, Jorge Cortes, Michele Baccarani, Meir Wetzler, Tamas Masszi, Raghunadharao Digumarti, Adam Craig, Annie-Claude Benichou & Luke Akard
Pages: 120-127
Published online: 28 Apr 2014
AbstractforOmacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors | Full Text | References | PDF (464.9 KB) | Supplemental
  • 548 Views
  • 24 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?
Joshua F. Zeidner, Marianna Zahurak, Gary L. Rosner, Christopher D. Gocke, Richard J. Jones & B. Douglas Smith
Pages: 128-134
Published online: 16 Jun 2014
AbstractforThe evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? | Full Text | References | PDF (269.7 KB) | Supplemental
  • 265 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia
Adam Bryant, Dawn Sheppard, Mitchell Sabloff, Michelle Delbaere, Ronnen Maze, David Allan, Harold Atkins, Isabelle Bence-Bruckler, Carolyn Faught, Lothar Huebsch, Jason Tay, Brent Zanke & Chris Bredeson
Pages: 135-140
Published online: 17 Jul 2014
AbstractforA single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia | Full Text | References | PDF (162.7 KB) | Supplemental
  • 229 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia
Chen Chen, Wei Xu & Jing Yang
Pages: 141-146
Published online: 16 Jun 2014
AbstractforLow-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia | Full Text | References | PDF (627.2 KB) | Supplemental
  • 192 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutations
Pierre Hirsch, Ghazi Qassa, Christophe Marzac, Ruoping Tang, Jean-Yves Perrot, Françoise Isnard, Mohamad Mohty, Jean Pierre Marie & Ollivier Legrand
Pages: 147-150
Published online: 16 Jun 2014
AbstractforAcute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutations | Full Text | References | PDF (269.6 KB) | Supplemental
  • 341 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt
Rabab M. Aly, Mona M. Taalab & Hayam F. Ghazy
Pages: 151-156
Published online: 17 Jun 2014
AbstractforInfluence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt | Full Text | References | PDF (217.7 KB) | Supplemental
  • 110 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis
Senthil M. Lingaratnam, Monica A. Slavin, Karin A. Thursky, Benjamin W. Teh, Gabrielle M. Haeusler, John F. Seymour, Danny Rischin & Leon J. Worth
Pages: 157-162
Published online: 09 Apr 2014
AbstractforPneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis | Full Text | References | PDF (531.4 KB) | Supplemental
  • 592 Views
  • 8 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population
Yat-Yuen Lim, Yoon-Ming Chin, Mei-Chee Tai, Somayeh Fani, Kian-Meng Chang, Tee-Chuan Ong, Ping-Chong Bee, Gin-Gin Gan & Ching-Ching Ng
Pages: 163-168
Published online: 06 May 2014
AbstractforAnalysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population | Full Text | References | PDF (536.4 KB) | Supplemental
  • 131 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Genetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk
Amy E. Kennedy, Kala Y. Kamdar, Philip J. Lupo, M. Fatih Okcu, Michael E. Scheurer & M. Tevfik Dorak
Pages: 169-174
Published online: 16 Jun 2014
AbstractforGenetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk | Full Text | References | PDF (139.2 KB) | Supplemental
  • 299 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
10p12.31-12.2 variants and risk of childhood acute lymphoblastic leukemia in a Chinese population
Jianping Deng, Yao Xue, Yaping Wang, Jing Chen, Jie Li, Qin Lu, Meilin Wang, Na Tong, Zhengdong Zhang & Yongjun Fang
Pages: 175-178
Published online: 16 Jun 2014
Abstractfor10p12.31-12.2 variants and risk of childhood acute lymphoblastic leukemia in a Chinese population | Full Text | References | PDF (120.2 KB) | Supplemental
  • 158 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations
Niklas Gebauer, Veronica Bernard, Wolfgang Gebauer, Christoph Thorns, Alfred C. Feller & Hartmut Merz
Pages: 179-185
Published online: 07 May 2014
AbstractforTP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations | Full Text | References | PDF (2 MB) | Supplemental
  • 837 Views
  • 51 CrossRef citations
  • 0Altmetric
Article
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease
Lan V. Pham, Muychi T. Vang, Archito T. Tamayo, Gary Lu, Pramoda Challagundla, Jeffrey L. Jorgensen, Alex A. Rollo, Zhishuo Ou, Liang Zhang, Michael Wang & Richard J. Ford
Pages: 186-193
Published online: 29 Apr 2014
AbstractforInvolvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease | Full Text | References | PDF (4.2 MB) | Supplemental
  • 347 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
PKD1 is critical for Epstein–Barr virus LMP1-induced protection of malignant B cells from cell death induced by rituximab
Joo Hyun Kim, Won Seog Kim & Chaehwa Park
Pages: 194-201
Published online: 25 Jun 2014
AbstractforPKD1 is critical for Epstein–Barr virus LMP1-induced protection of malignant B cells from cell death induced by rituximab | Full Text | References | PDF (2.3 MB) | Supplemental
  • 224 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Abnormal expression of CD66a promotes proliferation and inhibits apoptosis of human leukemic B cells in vitro
Wenjin Zhao, Yan Zhang, Dandan Liu, Liansheng Zhong, Qun He & Yujie Zhao
Pages: 202-210
Published online: 06 Jun 2014
AbstractforAbnormal expression of CD66a promotes proliferation and inhibits apoptosis of human leukemic B cells in vitro | Full Text | References | PDF (1.9 MB) | Supplemental
  • 146 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Up-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells
Xiaohui Zhang, Yu Sun, Ziyan Wang, Zhanping Huang, Bingzong Li & Jinxiang Fu
Pages: 211-218
Published online: 16 Jun 2014
AbstractforUp-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells | Full Text | References | PDF (2.7 MB) | Supplemental
  • 464 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
Daisuke Ito, Susan Brewer, Jaime F. Modiano & Melissa J. Beall
Pages: 219-225
Published online: 16 Jun 2014
AbstractforDevelopment of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential | Full Text | References | PDF (942.5 KB) | Supplemental
  • 692 Views
  • 37 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies
James M. Bogenberger, Devora Delman, Nanna Hansen, Riccardo Valdez, Veena Fauble, Ruben A. Mesa & Raoul Tibes
Pages: 226-229
Published online: 17 Jun 2014
First Page PreviewforEx vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies | Full Text | References | PDF (655 KB) | Supplemental
  • 1021 Views
  • 103 CrossRef citations
  • 0Altmetric

Commentary on selected article in this issue

Letter
Splenectomy and second malignancies in patients with Hodgkin lymphoma
Hilde A. M. Kooistra, Hanneke C. Kluin-Nelemans, Gustaaf W. van Imhoff, Boukje A. C. van Dijk, Geertruida H. de Bock & Marleen A. E. van der Kaaij
Pages: 230-231
Published online: 12 May 2014
CitationforSplenectomy and second malignancies in patients with Hodgkin lymphoma | Full Text | References | PDF (107.4 KB) | Supplemental
  • 122 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia
Victor H. Jimenez-Zepeda, Donna E. Reece, Suzanne Trudel, Christine Chen, Rodger Tiedemann & Vishal Kukreti
Pages: 232-235
Published online: 27 Jun 2014
First Page PreviewforLenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia | Full Text | References | PDF (135.9 KB) | Supplemental
  • 619 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Bone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern
Poonam Panjwani, Sridhar Epari, Manju Sengar, Siddhartha Laskar, Hari Menon & Tanuja Shet
Pages: 236-238
Published online: 27 Jun 2014
First Page PreviewforBone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern | Full Text | References | PDF (577.2 KB) | Supplemental
  • 228 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Clonal dominance and clonal evolution in a patient with a “chronic myeloid neoplasm”: a challenge in management
Sonja Burgstaller, Gerald Webersinke & Josef Thaler
Pages: 239-241
Published online: 27 Jun 2014
First Page PreviewforClonal dominance and clonal evolution in a patient with a “chronic myeloid neoplasm”: a challenge in management | Full Text | References | PDF (472.2 KB) | Supplemental
  • 81 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia
Sílvia Saumell, Lourdes Florensa, María Rodríguez-Rivera, Carme Pedro, Jesús María Hernández-Rivas, Eva Lumbreras, María Abáigar, Rosa Collado, David Ivars, Félix Carbonell, Isabel Marugán, Mar Tormo, Mercedes Botia, María Ángeles Piñan, Idoia Ancín, Teresa González, Nicolás Díaz Varela, Javier Grau, Isabel Granada, Neus Ruiz, María Luisa Martín, Manuela Fernández-Guijarro, José-Joaquín Duarte, María José Calasanz, María José Larrayoz & Francesc Solé
Pages: 242-243
Published online: 25 Jun 2014
CitationforFluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia | Full Text | References | PDF (93 KB) | Supplemental
  • 98 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor
Emi Togasaki, Katsuhiro Shono, Masahiro Onoda & Akira Yokota
Pages: 244-247
Published online: 25 Jun 2014
First Page PreviewforRetrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor | Full Text | References | PDF (142.4 KB) | Supplemental
  • 232 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Successful management of Rothia aeria pneumonia during the peritransplant period: first reported case in allogeneic hematopoietic stem cell transplant
Masahiro Uni, Akihito Shinohara, Arika Nukina, Fumihiko Nakamura, Yasuhito Nannya, Miyuki Mizoguchi, Mitsuhiro Okazaki, Keita Tatsuno, Kyoji Moriya & Mineo Kurokawa
Pages: 248-250
Published online: 27 Jun 2014
First Page PreviewforSuccessful management of Rothia aeria pneumonia during the peritransplant period: first reported case in allogeneic hematopoietic stem cell transplant | Full Text | References | PDF (246.9 KB) | Supplemental
  • 195 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Childhood acute lymphoblastic leukemia: 12 years of experience, using a Berlin–Frankfurt–Münster approach, in a Greek center
Maria Ampatzidou, John P. Panagiotou, Georgios Paterakis, Vassilios Papadakis, Stephanos I. Papadhimitriou, Agapi Parcharidou, Sophia Papargyri, Efthimia Rigatou, Georgia Avgerinou, Konstantinos Tsitsikas, Vassilios Vasdekis, Stavros Haidas & Sophia Polychronopoulou
Pages: 251-255
Published online: 27 Jun 2014
First Page PreviewforChildhood acute lymphoblastic leukemia: 12 years of experience, using a Berlin–Frankfurt–Münster approach, in a Greek center | Full Text | References | PDF (179.2 KB) | Supplemental
  • 88 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Prognostic significance of [18F]fluorodeoxyglucose-positron emission tomography in peripheral T-cell lymphoma treated with stem cell transplantation: a retrospective analysis
Lauren Shea, Jingxia Liu & Amanda Cashen
Pages: 256-259
Published online: 16 May 2014
First Page PreviewforPrognostic significance of [18F]fluorodeoxyglucose-positron emission tomography in peripheral T-cell lymphoma treated with stem cell transplantation: a retrospective analysis | Full Text | References | PDF (188.2 KB) | Supplemental
  • 110 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Transplant related outcomes in patients with hematopoietic stem cell transplant with Clostridium difficile associated diarrhea
Kari Neemann, Veenu Minhas, Fausto R. Loberiza & Alison Freifield
Pages: 260-262
Published online: 27 Jun 2014
First Page PreviewforTransplant related outcomes in patients with hematopoietic stem cell transplant with Clostridium difficile associated diarrhea | Full Text | References | PDF (132.7 KB) | Supplemental
  • 175 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma
Penny Anders, Prasanna M. Bhende, Michael Foote, Dirk P. Dittmer, Steven I. Park & Blossom Damania
Pages: 263-266
Published online: 06 Jun 2014
First Page PreviewforDual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma | Full Text | References | PDF (2.7 MB) | Supplemental
  • 193 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience
Chiara Cattaneo, Alessandro Re, Marco Ungari, Annalisa Peli, Salvatore Casari, Filippo Castelnuovo, Simona Fisogni, Silvia Lonardi, Vilma Pellegrini, Marta Petullà, Fabio Facchetti & Giuseppe Rossi
Pages: 267-269
Published online: 16 Jun 2014
First Page PreviewforPlasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience | Full Text | References | PDF (128.7 KB) | Supplemental
  • 383 Views
  • 26 CrossRef citations
  • 0Altmetric
Letter
Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma
Zhao Hong-Xia, Sun Wan-Jun, Li Jie, Hu Hai-Lan & Ai Hui-Sheng
Pages: 270-273
Published online: 27 Jun 2014
First Page PreviewforProgrammed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma | Full Text | References | PDF (135.6 KB) | Supplemental
  • 129 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles